RxDoctor Payments Data

Elissa Malkin

Family Medicine · Washington, DCNPI 1285194977

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,500 of the $2,500 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Novavax Inc. Among family medicine clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,500in general payments, 2019–2025

Across 2 payments — averaging $1250.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novavax Inc$3K
$570,700in research payments, 2019–2025

Across 46 payments — averaging $12,407 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$569K
  • Novavax Inc$1K

What the payments were for

  • Consulting fees$2,500100%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novavax Inc2$2,500

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,500 in reported general payments places this provider in the 90th percentile of 166 family medicine providers in District of Columbia.

See all family medicine providers in District of Columbia →

Other family medicine in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →